S-1 · resale registration
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
ADVB$2.22+6.99%
Advanced Biomed Inc.
Sector: Services-Medical LaboratoriesIndustry: Medical - Diagnostics & ResearchCountry: USExchange: Nasdaq
Mkt Cap:$3.67M
Float & O/S:
Inst Own:
DilutionScan read 12 of Advanced Biomed Inc.'s SEC filings and found 1 warrant series, 1 equity line, 2 S-1 registrations and 3 completed offerings on file for ADVB. The latest dilution event on file is an offering on Apr 30, 2026. Analysis updated Oct 19, 2026.
Signal8 Summary
ADVB
Going-concern warning and business pivot
Snapshot
Advanced Biomed is a pre-revenue micro-cap in the middle of a drastic identity change. FY 2025 financials show $0 in revenue and a $102K net loss, but the company has signaled a shift away from its core bio-med R&D toward AI financial audit solutions.
What's Happening Right Now
- : The company agreed to sell its Taiwan subsidiary, which contains its core biomedical R&D operations, for $490,000.
- : The company disclosed a going-concern warning despite reporting a one-time profit, citing cash outflows and reliance on external financing.
Raise routes on file: no active ATM, effective shelf, S-1 or equity line in the filings read · latest dilution event 187 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Apr 30, 2026 · Offering
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Withdrawn
S-1 · primary and resale
Issued 2023
Proposed maximum
Shares registered
- Filed
- Effective
Warrant
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Equity line
Issued 2025
Commitment
Sold to date
Remaining
- Agreement date
- Term ends
- Discount
PIPE
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Offering
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Offering
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your ADVB trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
